Has COVID-19 Indefinitely Disrupted the Pharma Sales Model?
17 August 2020
In March, COVID-19 halted face to face Pharma sales teams, as healthcare systems start to open up, we ask has the model been indefinitely changed?Read more
The Gene Therapy Revolution Has Arrived. But What’s Next?
04 August 2020
Three gene therapies have been successfully been approved over the last 2 years, revolutionising the treatment of rare, detrimental diseases. The landscape is now blossoming with hundreds of gene therapies in clinical development.Read more
Managing cancer patients during the COVID-19 pandemic
26 June 2020
COVID-19 has impacted all aspects of clinical care globally, including #cancer treatment. A delicate balance needs to be struck between mitigating risk of potential exposure and continuing to ensure access to #cancer treatment and clinical trials.Read more
COVID-19 Dissecting the Therapeutic and Vaccine Landscape
28 April 2020
We take a look at where does the most promise lie amidst this rapidly evolving landscape and when will therapeutic studies yield firm evidence of clinical benefit.Read more
Will PSMA-targeting diagnostics and therapeutics revolutionize Prostate Cancer care?
29 January 2020
PSMA-based imaging is poised to be widely adopted as standard imaging practice in prostate cancerRead more